Predictive Value of the Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Index on the Oncological Outcomes of Locally Advanced Cervical Cancer Patients
Kittinun Leetanaporn,Jitti Hanprasertpong
DOI: https://doi.org/10.2147/CMAR.S365612
2022-06-14
Cancer Management and Research
Abstract:Kittinun Leetanaporn, 1 Jitti Hanprasertpong 2 1 Department of Biomedical Science and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Songkhla, 90110, Thailand; 2 Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, 90110, Thailand Correspondence: Jitti Hanprasertpong, Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, 90110, Thailand, Tel +66 74 45 1201, Fax +66 74 429 617, Email ; Purpose: The oncological outcomes of locally advanced cervical cancer (LACC) patients after treatment are poor and heterogeneous. This study aimed to determine the role of the hemoglobin-albumin-lymphocyte-platelet (HALP) inflammatory index in predicting oncological outcomes in LACC patients. Patients and Methods: A total of 1588 LACC patients who received radiation therapy or concurrent chemoradiation were divided into training and test sets. Characteristics, survival, and a HALP cutoff determined by X-tile software were used to build predictive survival models on the training data. Validation of the model was performed on both sets. Results: Patients with a HALP score ≤ 22.2 tended to have lower age (p < 0.001), lower comorbidity rate (p = 0.016), lower body mass index (p < 0.001), higher stage (p < 0.001), larger tumor size (p < 0.001), and higher likelihood to receive radiation alone than concurrent chemoradiation (p 22.2 was independently associated with better progression-free survival (PFS; hazard ratio; HR 0.55) and overall survival (OS; HR 0.43). Validation of survival prediction by receiver-operating characteristics demonstrated a significantly improved area under the curve of survival prediction in both sets (p < 0.001) after the addition of the HALP index to the model. Conclusion: A lower HALP score was an independent predictive factor for poorer oncological outcomes. The addition of the HALP index can improve the accuracy of predicting the oncological outcomes of LACC patients. Keywords: cervical cancer, hemoglobin-albumin-lymphocyte-platelet index, survival, radiotherapy, predictive model Cervical cancer (CC) is one of the most burdensome malignancies worldwide. Despite the global downward trend owing to the availability of vaccinations and pap smears, the prevalence of CC is still high in many countries, especially in developing regions. 1 In locally advanced CC (LACC), radiation alone (RT) or concurrent chemoradiation (CCRT) is the mainstay treatment, 2 with a wide survival range of 20.9–71.5%. 3–5 Thus, additional parameters that can help stratify CC oncological outcomes are still desirable. Following this research in recent years, several novel biomarkers have been discovered, which assist in improved prognosis determination after treatments, such as the squamous cell antigen (SCC-Ag) and HPV-DNA. 6,7 However, these biomarkers have relatively high costs and are not part of a routine examination. Therefore, a combination of pre-treatment laboratory investigations with relatively high accuracy and low cost is still in demand for determining the prognosis of an individual CC patient. There has been evidence reported on the linkage between inflammation, nutritional status, and cancer progression. 8–11 Chronic inflammation accelerates the release of various cytokines that enhance cancer growth by inhibiting apoptosis and accommodating a neovascularization process leading to cancer progression. 8 It is also understood that poor nutritional status in cancer patients causes impaired immune function, increased inflammatory response, and leads to increased treatment side effects. 9,10 Additionally, malnutrition status can reflect high tumor metabolic activity since cancer supplies itself with extra energy by taking it from the surrounding environment. 11 For this reason, several inflammatory indices have been established to identify the clinical association between inflammation and cancer prognosis, such as C-reactive protein, lactate dehydrogenase, neutrophil-to-lymphocyte ratio (NLR); 12–14 nutritional status indices such as body mass index (BMI) and prognostic nutrition index. 15,16 The hemoglobin-albumin-lymphocyte-platelet (HALP) index is a novel score based on a combination of inflammatory and nutritional deficiency concepts. This index has been found to enhance the prediction accuracy of various cancer prognoses. 17–19 However, there are, to date, no studies on the effect of this index on CC prognoses. Therefore, this study aimed to examine the prognostic role of the HALP index on on -Abstract Truncated-
oncology